Robotic Vascular Catheter System Market Size, Share, and Trends Analysis - Global - 2025-2031 - Includes: Capital Equipment Market, Disposable and Other Accessories Market, and 1 more
Description
Global Robotic Vascular Catheter System Market Report, 2025 Edition
Executive Summary
The global robotic vascular catheter system market was valued at approximately 250 million dollars in 2024. The market is expected to grow at a 12.6 percent CAGR, reaching nearly 570 million dollars by 2031. Growth will be driven by clinical demand for greater precision in vascular procedures, expanded adoption in major regions and increased utilization of minimally invasive techniques in interventional cardiology and peripheral vascular care.
This report covers capital robotic catheter systems, disposables and other accessories, and services and maintenance revenue. It includes unit sales, procedure volumes, average selling prices, market values, growth rates and competitive shares. It also reviews mergers and acquisitions, technology uptake, regional adoption pathways and the shift of robotic procedures into routine interventional workflows.
North America represented the largest share of the global market in 2024, followed by Western Europe and Asia Pacific. Together, these three regions accounted for more than 80 percent of the market value. Asia Pacific and North America are forecast to grow at the fastest pace, while Latin America is projected to show the strongest growth rate among smaller markets. The global market is supported by the rising burden of cardiovascular and neurovascular disease, physician interest in robotics for radiation protection and a growing commitment by hospitals to differentiate themselves through advanced interventional technologies.
Market Overview
Robotic vascular catheter systems are designed to enhance the precision, safety and efficiency of procedures that require catheter navigation through the vascular system. These systems reduce radiation exposure to physicians, allow for millimeter-scale manipulation of devices and replicate or improve upon traditional manual techniques.
Historically, robotic vascular systems were used only in a limited number of complex interventions. However, rising demand for consistency and accuracy in minimally invasive procedures is accelerating adoption across cardiology, electrophysiology and select endovascular applications. The global installed base continues to expand as hospitals view robotics as a strategic investment that supports surgeon recruitment, operational differentiation and improved clinical outcomes.
The 2025 edition of this report examines current procedure growth, installed base expansion, evolving business models, and the increasing involvement of major global manufacturers. With procedure growth expected in both established regions and emerging markets, the robotic vascular catheter system market is positioned for continued expansion through 2031.
Market Drivers
Clinical Benefits
Two of the most important benefits of robotic vascular catheter systems are radiation protection and enhanced precision. Interventional specialists are consistently exposed to radiation during catheter procedures and must wear lead protective garments, which increases long-term risk for orthopedic injuries such as interventional disc disease. Robotic navigation removes the clinician from the radiation field and reduces the need for protective gear. This improves occupational safety and reduces clinician fatigue.
Robotic systems also enable millimeter-level device movements, which improve precision and reduce procedural complications. For vascular interventions requiring fine control, the ability to navigate tight anatomical structures more steadily and with fewer adjustments is a major clinical advantage. As more studies demonstrate reductions in patient exposure, catheter manipulation time and adverse events, clinical confidence in robotics continues to grow.
Recruitment Competition
Hospitals increasingly compete for skilled specialists, and robotic vascular systems have become a key differentiator. Many interventional cardiologists and electrophysiologists prefer facilities equipped with the newest robotic technology, as it enhances their efficiency and long-term career safety. Hospitals adopt robotic systems not only for clinical benefit but also to position themselves as leaders in advanced cardiovascular care.
The visibility provided by robotics supports hospital branding, strengthens physician recruitment and improves patient perception of care quality. These factors collectively support increased installations and procedure growth.
Revenue from Alternate Sources
Robotic vascular catheter manufacturers generate revenue not only from system sales but also from disposables, accessories, services and maintenance contracts. In many regions, this recurring revenue segment makes up a large portion of total market value. As the installed base expands, revenue from these ancillary components increases accordingly.
This also creates long-term financial justification for manufacturers to maintain system affordability at the capital level, allowing broader access for hospitals that would otherwise be unable to adopt robotics.
Market Limiters
Cost of Using Robotic Systems
The high cost of robotic systems is the primary barrier to adoption. Capital systems can exceed several hundred thousand dollars, and ongoing service fees add to the total cost of ownership. Hospitals with limited budgets must choose between robotics and other major investments, such as imaging systems or implant inventory.
Robotics-focused companies rely heavily on capital sales, and competition among systems with different procedural specialties can limit the ability of manufacturers to scale adoption quickly. In the vascular segment, robust capital justification is required for purchase approval, which slows adoption in cost-sensitive markets.
Training Period
Robotic systems require structured training, and surgeons often need multiple procedures to gain proficiency. Since not all clinicians are comfortable with robotic navigation, procedure volumes may be limited during the early adoption period. This can hinder hospital efficiency and delay return on investment.
Manufacturers provide training programs, proctoring and on-site support to accelerate learning, but the time needed to build surgeon confidence remains a restraining factor, particularly in high-volume centers that cannot afford slowdowns in workflow.
Regulation
Robotic vascular catheter systems must comply with strict regulatory requirements in all global markets. As regulation becomes more stringent, approval timelines lengthen. This slows the introduction of new systems, new indications and software updates. The complexity of navigating multi-regional regulatory frameworks also increases development costs for manufacturers.
Delays in regulatory approval can postpone product launches and limit short-term market penetration. This is especially significant for companies expanding into multiple interventional specialties.
Market Coverage and Data Scope
Quantitative coverage: Market size, market shares, market forecasts, growth rates, units sold, and ASPs.
Qualitative coverage: Growth trends, market limiters, competitive analysis, SWOT for leading competitors, mergers and acquisitions, company profiles, product portfolios, disruptive technologies, and disease overviews.
Time frame: Base year 2024, forecasts to 2031, historical data 2021–2023.
Data sources: Primary interviews with orthopedic industry leaders, surgeon surveys, regulatory data, hospital procurement databases, and iData Research’s internal MedTech repository.
Method note: Market revenue is modeled as units × ASP, validated with procedural data and replacement cycle assumptions
Care settings include hospitals, orthopedic specialty centers, and ambulatory surgery centers (ASCs) across major global regions.
Markets Covered and Segmentation
This report categorizes the global robotic vascular catheter system market into the following revenue segments:
Robotic Vascular Catheter System Market by Revenue Type
Capital Equipment
Disposables and Other Accessories
Service and Maintenance Revenue
Each segment includes regional units, ASPs, market values and forecast growth to 2032. Procedure volumes using robotic vascular catheter systems are also provided.
Competitive Analysis
The competitive landscape of the robotic vascular catheter market continues to evolve, with several major manufacturers positioning themselves for long-term growth. The market remains dominated by companies with strong portfolios in robotics, vascular navigation and advanced imaging integration.
Johnson & Johnson (Auris Health)
Johnson & Johnson, through its subsidiary Auris Health, held the leading share of the global robotic vascular catheter system market in 2024. Its leadership was strengthened by the acquisition of Hansen Medical in 2016, which brought established robotic catheter brands into its portfolio.
Auris Health currently markets:
Magellan
Sensei
Artisan Extend Control Catheter systems
These systems are widely recognized for their precision and broad range of vascular applications. Johnson & Johnson’s strong global distribution and long-term commitment to robotics support its ongoing leadership.
Stereotaxis
Stereotaxis held the second-largest share of the global market in 2024. The company markets several systems, including:
Vdrive Robotic Navigation System
Niobe Robotic Magnetic Navigation System
Odyssey Vision System
Genesis RMN System
In July 2022, Stereotaxis received CE mark approval for MAGiC, its robotically navigated magnetic interventional catheter. Continuous innovation in magnetic navigation and catheter control has made Stereotaxis a key competitor, especially in electrophysiology.
Siemens Healthineers (Corindus Vascular Robotics)
Siemens Healthineers, through Corindus Vascular Robotics, held the third-largest position in 2024. The company markets:
CorPath GRX, its next-generation vascular robotics platform, which builds on the CorPath Vascular Robotic System.
The system was involved in the first successful remote PCI cases in India, demonstrating the potential of tele-robotic vascular care. In 2023, Siemens announced a strategic shift to focus its endovascular robotic platform exclusively on interventional neurology while exiting the cardiovascular robotics segment. Despite this adjustment, its installed base and technological leadership support ongoing system utilization and service revenue.
Geography
This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.
Why This Report
Where are the largest and fastest‑growing opportunities in the global diagnostic and interventional catheter market?
Which catheter technologies and product categories are expected to gain the most share through 2031?
How are advanced imaging, robotics, and minimally invasive techniques influencing procedural outcomes?
What are the pricing and regulatory challenges shaping product launches in emerging markets?
How is outpatient migration and ASC adoption impacting procurement strategies for catheter‑based procedures?
Which companies lead in each segment, and what are their innovation roadmaps?
What are the key risks to growth, including regulatory delays, physician shortages, and reimbursement constraints?
How can suppliers align portfolios, training programs, and service models to meet the next wave of demand?
The Global Robotic Vascular Catheter System Market from iData Research answers these questions with procedure‑based models, company share analysis, and detailed pricing data. Use it to quantify demand, benchmark competitors, and plan for growth across all catheter categories.
About iData Research
iData Research is a premium market intelligence firm headquartered in Canada with offices across North America and Europe.
Over the last 20 years, the company has specialized in device-level sizing, procedure models, pricing trends, and competitive share across MedTech.
Since 2005, iData has supported global OEMs, mid-market innovators, and investors with triangulated data based on units and ASPs, with country-level forecasts and analyst access across Europe, North America, Latin America, the Middle East, Africa, and APAC.
Reports are available with flexible licensing to fit commercial, strategy, and investment workflows
Executive Summary
The global robotic vascular catheter system market was valued at approximately 250 million dollars in 2024. The market is expected to grow at a 12.6 percent CAGR, reaching nearly 570 million dollars by 2031. Growth will be driven by clinical demand for greater precision in vascular procedures, expanded adoption in major regions and increased utilization of minimally invasive techniques in interventional cardiology and peripheral vascular care.
This report covers capital robotic catheter systems, disposables and other accessories, and services and maintenance revenue. It includes unit sales, procedure volumes, average selling prices, market values, growth rates and competitive shares. It also reviews mergers and acquisitions, technology uptake, regional adoption pathways and the shift of robotic procedures into routine interventional workflows.
North America represented the largest share of the global market in 2024, followed by Western Europe and Asia Pacific. Together, these three regions accounted for more than 80 percent of the market value. Asia Pacific and North America are forecast to grow at the fastest pace, while Latin America is projected to show the strongest growth rate among smaller markets. The global market is supported by the rising burden of cardiovascular and neurovascular disease, physician interest in robotics for radiation protection and a growing commitment by hospitals to differentiate themselves through advanced interventional technologies.
Market Overview
Robotic vascular catheter systems are designed to enhance the precision, safety and efficiency of procedures that require catheter navigation through the vascular system. These systems reduce radiation exposure to physicians, allow for millimeter-scale manipulation of devices and replicate or improve upon traditional manual techniques.
Historically, robotic vascular systems were used only in a limited number of complex interventions. However, rising demand for consistency and accuracy in minimally invasive procedures is accelerating adoption across cardiology, electrophysiology and select endovascular applications. The global installed base continues to expand as hospitals view robotics as a strategic investment that supports surgeon recruitment, operational differentiation and improved clinical outcomes.
The 2025 edition of this report examines current procedure growth, installed base expansion, evolving business models, and the increasing involvement of major global manufacturers. With procedure growth expected in both established regions and emerging markets, the robotic vascular catheter system market is positioned for continued expansion through 2031.
Market Drivers
Clinical Benefits
Two of the most important benefits of robotic vascular catheter systems are radiation protection and enhanced precision. Interventional specialists are consistently exposed to radiation during catheter procedures and must wear lead protective garments, which increases long-term risk for orthopedic injuries such as interventional disc disease. Robotic navigation removes the clinician from the radiation field and reduces the need for protective gear. This improves occupational safety and reduces clinician fatigue.
Robotic systems also enable millimeter-level device movements, which improve precision and reduce procedural complications. For vascular interventions requiring fine control, the ability to navigate tight anatomical structures more steadily and with fewer adjustments is a major clinical advantage. As more studies demonstrate reductions in patient exposure, catheter manipulation time and adverse events, clinical confidence in robotics continues to grow.
Recruitment Competition
Hospitals increasingly compete for skilled specialists, and robotic vascular systems have become a key differentiator. Many interventional cardiologists and electrophysiologists prefer facilities equipped with the newest robotic technology, as it enhances their efficiency and long-term career safety. Hospitals adopt robotic systems not only for clinical benefit but also to position themselves as leaders in advanced cardiovascular care.
The visibility provided by robotics supports hospital branding, strengthens physician recruitment and improves patient perception of care quality. These factors collectively support increased installations and procedure growth.
Revenue from Alternate Sources
Robotic vascular catheter manufacturers generate revenue not only from system sales but also from disposables, accessories, services and maintenance contracts. In many regions, this recurring revenue segment makes up a large portion of total market value. As the installed base expands, revenue from these ancillary components increases accordingly.
This also creates long-term financial justification for manufacturers to maintain system affordability at the capital level, allowing broader access for hospitals that would otherwise be unable to adopt robotics.
Market Limiters
Cost of Using Robotic Systems
The high cost of robotic systems is the primary barrier to adoption. Capital systems can exceed several hundred thousand dollars, and ongoing service fees add to the total cost of ownership. Hospitals with limited budgets must choose between robotics and other major investments, such as imaging systems or implant inventory.
Robotics-focused companies rely heavily on capital sales, and competition among systems with different procedural specialties can limit the ability of manufacturers to scale adoption quickly. In the vascular segment, robust capital justification is required for purchase approval, which slows adoption in cost-sensitive markets.
Training Period
Robotic systems require structured training, and surgeons often need multiple procedures to gain proficiency. Since not all clinicians are comfortable with robotic navigation, procedure volumes may be limited during the early adoption period. This can hinder hospital efficiency and delay return on investment.
Manufacturers provide training programs, proctoring and on-site support to accelerate learning, but the time needed to build surgeon confidence remains a restraining factor, particularly in high-volume centers that cannot afford slowdowns in workflow.
Regulation
Robotic vascular catheter systems must comply with strict regulatory requirements in all global markets. As regulation becomes more stringent, approval timelines lengthen. This slows the introduction of new systems, new indications and software updates. The complexity of navigating multi-regional regulatory frameworks also increases development costs for manufacturers.
Delays in regulatory approval can postpone product launches and limit short-term market penetration. This is especially significant for companies expanding into multiple interventional specialties.
Market Coverage and Data Scope
Quantitative coverage: Market size, market shares, market forecasts, growth rates, units sold, and ASPs.
Qualitative coverage: Growth trends, market limiters, competitive analysis, SWOT for leading competitors, mergers and acquisitions, company profiles, product portfolios, disruptive technologies, and disease overviews.
Time frame: Base year 2024, forecasts to 2031, historical data 2021–2023.
Data sources: Primary interviews with orthopedic industry leaders, surgeon surveys, regulatory data, hospital procurement databases, and iData Research’s internal MedTech repository.
Method note: Market revenue is modeled as units × ASP, validated with procedural data and replacement cycle assumptions
Care settings include hospitals, orthopedic specialty centers, and ambulatory surgery centers (ASCs) across major global regions.
Markets Covered and Segmentation
This report categorizes the global robotic vascular catheter system market into the following revenue segments:
Robotic Vascular Catheter System Market by Revenue Type
Capital Equipment
Disposables and Other Accessories
Service and Maintenance Revenue
Each segment includes regional units, ASPs, market values and forecast growth to 2032. Procedure volumes using robotic vascular catheter systems are also provided.
Competitive Analysis
The competitive landscape of the robotic vascular catheter market continues to evolve, with several major manufacturers positioning themselves for long-term growth. The market remains dominated by companies with strong portfolios in robotics, vascular navigation and advanced imaging integration.
Johnson & Johnson (Auris Health)
Johnson & Johnson, through its subsidiary Auris Health, held the leading share of the global robotic vascular catheter system market in 2024. Its leadership was strengthened by the acquisition of Hansen Medical in 2016, which brought established robotic catheter brands into its portfolio.
Auris Health currently markets:
Magellan
Sensei
Artisan Extend Control Catheter systems
These systems are widely recognized for their precision and broad range of vascular applications. Johnson & Johnson’s strong global distribution and long-term commitment to robotics support its ongoing leadership.
Stereotaxis
Stereotaxis held the second-largest share of the global market in 2024. The company markets several systems, including:
Vdrive Robotic Navigation System
Niobe Robotic Magnetic Navigation System
Odyssey Vision System
Genesis RMN System
In July 2022, Stereotaxis received CE mark approval for MAGiC, its robotically navigated magnetic interventional catheter. Continuous innovation in magnetic navigation and catheter control has made Stereotaxis a key competitor, especially in electrophysiology.
Siemens Healthineers (Corindus Vascular Robotics)
Siemens Healthineers, through Corindus Vascular Robotics, held the third-largest position in 2024. The company markets:
CorPath GRX, its next-generation vascular robotics platform, which builds on the CorPath Vascular Robotic System.
The system was involved in the first successful remote PCI cases in India, demonstrating the potential of tele-robotic vascular care. In 2023, Siemens announced a strategic shift to focus its endovascular robotic platform exclusively on interventional neurology while exiting the cardiovascular robotics segment. Despite this adjustment, its installed base and technological leadership support ongoing system utilization and service revenue.
Geography
This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.
Why This Report
Where are the largest and fastest‑growing opportunities in the global diagnostic and interventional catheter market?
Which catheter technologies and product categories are expected to gain the most share through 2031?
How are advanced imaging, robotics, and minimally invasive techniques influencing procedural outcomes?
What are the pricing and regulatory challenges shaping product launches in emerging markets?
How is outpatient migration and ASC adoption impacting procurement strategies for catheter‑based procedures?
Which companies lead in each segment, and what are their innovation roadmaps?
What are the key risks to growth, including regulatory delays, physician shortages, and reimbursement constraints?
How can suppliers align portfolios, training programs, and service models to meet the next wave of demand?
The Global Robotic Vascular Catheter System Market from iData Research answers these questions with procedure‑based models, company share analysis, and detailed pricing data. Use it to quantify demand, benchmark competitors, and plan for growth across all catheter categories.
About iData Research
iData Research is a premium market intelligence firm headquartered in Canada with offices across North America and Europe.
Over the last 20 years, the company has specialized in device-level sizing, procedure models, pricing trends, and competitive share across MedTech.
Since 2005, iData has supported global OEMs, mid-market innovators, and investors with triangulated data based on units and ASPs, with country-level forecasts and analyst access across Europe, North America, Latin America, the Middle East, Africa, and APAC.
Reports are available with flexible licensing to fit commercial, strategy, and investment workflows
Table of Contents
81 Pages
- Research Methodology
- Step 1: Project Initiation & Team Selection
- Step 2: Prepare Data Systems And Perform Secondary Research
- Step 3: Preparation For Interviews & Questionnaire Design
- Step 4: Performing Primary Research
- Step 5: Research Analysis: Establishing Baseline Estimates
- Step 6: Market Forecast And Analysis
- Step 7: Identify Strategic Opportunities
- Step 8: Final Review And Market Release
- Step 9: Customer Feedback And Market Monitoring
- Disease Overview
- 2.1 Medical Conditions
- 2.1.1 Cardiac Conditions
- 2.1.1.1 Coronary Artery Disease
- 2.1.1.2 Mitral Valve Prolapse
- 2.1.2 Colorectal Conditions
- 2.1.2.1 Colorectal Cancer
- 2.1.2.2 Diverticulitis
- 2.1.2.3 Inflammatory Bowel Disease
- 2.1.3 Digestive Tract Conditions
- 2.1.3.1 Achalasia
- 2.1.3.2 Gallbladder Attack
- 2.1.3.3 Gastroesophageal Reflux Disease
- 2.1.3.4 Hernia
- 2.1.3.5 Stomach Cancer
- 2.1.4 Ear, Nose And Throat (Ent) Conditions
- 2.1.4.1 Cholesteatomas
- 2.1.4.2 Chronic Sinusitis
- 2.1.4.3 Otitis Media
- 2.1.4.4 Otosclerosis
- 2.1.4.5 Tonsillitis
- 2.1.5 Gynecological Conditions
- 2.1.5.1 Endometriosis
- 2.1.5.2 Gynecological Cancers
- 2.1.5.3 Menorrhagia
- 2.1.5.4 Pelvic Prolapse
- 2.1.5.5 Uterine Fibroids
- 2.1.6 Neurosurgical Conditions
- 2.1.6.1 Brain Tumor
- 2.1.6.2 Communicating Hydrocephalus
- 2.1.6.3 Hydrocephalus
- 2.1.6.4 Intracranial Aneurysm
- 2.1.6.5 Intracranial Atherosclerosis Disease
- 2.1.6.6 Intracranial Pressure
- 2.1.6.7 Non-Communicating Hydrocephalus
- 2.1.6.8 Normal Pressure Hydrocephalus
- 2.1.7 Orthopedic Conditions
- 2.1.7.1 Arthritis
- 2.1.7.2 Fractures
- 2.1.7.3 Osteoporosis
- 2.1.8 Spinal Conditions
- 2.1.8.1 Herniated Disc
- 2.1.8.2 Kyphosis
- 2.1.8.3 Scoliosis
- 2.1.8.4 Spinal Stenosis
- 2.1.8.5 Spondylosis
- 2.1.9 Urological Conditions
- 2.1.9.1 Benign Prostatic Hyperplasia (Bph)
- 2.1.9.2 Bladder Cancer
- 2.1.9.3 Kidney Cancer
- 2.1.9.4 Prostate Cancer
- Robotic Vascular Catheter System Market
- 15.1 Executive Summary
- 15.1.1 Global Robotic Vascular Catheter System Market Overview
- 15.1.2 Competitive Analysis
- 15.1.3 Market Segmentation
- 15.1.4 Regions Included
- 15.2 Introduction
- 15.3 Procedure Numbers
- 15.4 Market Overview
- 15.4.1 By Segment
- 15.4.2 By Region
- 15.5 Market Analysis And Forecast
- 15.5.1 Robotic Vascular Catheter Capital Equipment Market
- 15.5.2 Robotic Vascular Catheter Disposables And Other Accessories Market
- 15.5.3 Robotic Vascular Catheter System Service And Maintenance Revenue Market
- 15.6 Drivers And Limiters
- 15.6.1 Market Drivers
- 15.6.2 Market Limiters
- 15.7 Competitive Market Share Analysis
- Abbreviations
- Chart 15-1: Robotic Vascular Catheter System Market, Global, 2024 & 2031
- Chart 15-2: Robotic Vascular Catheter System Procedures, Global, 2024
- Chart 15-3: Robotic-Assisted Vascular Catheter Placement Procedures by Region, Global, 2021 – 2031
- Chart 15-4: Robotic Vascular Catheter System Market by Segment, Global, 2021 – 2031
- Chart 15-5: Robotic Vascular Catheter System Market by Region, Global, 2021 – 2031
- Chart 15-6: Leading Competitors, Robotic Vascular Catheter System Market, Global, 2024
- Figure 15-1: Robotic Vascular Catheter System Market Segmentation
- Figure 15-2: Robotic Vascular Catheter System Regions Covered, Global (1 of 2)
- Figure 15-3: Robotic Vascular Catheter System Regions Covered, Global (2 of 2)
- Figure 15-4: Robotic-Assisted Vascular Catheter Placement Procedures by Region, Global, 2021 – 2031
- Figure 15-5: Robotic-Assisted Vascular Catheter Placement Procedures by Country, North America, 2021 – 2031
- Figure 15-6: Robotic-Assisted Vascular Catheter Placement Procedures by Country, Latin America, 2021 – 2031 (1 of 2)
- Figure 15-7: Robotic-Assisted Vascular Catheter Placement Procedures by Country, Latin America, 2021 – 2031 (2 of 2)
- Figure 15-8: Robotic-Assisted Vascular Catheter Placement Procedures by Country, Western Europe, 2021 – 2031
- Figure 15-9: Robotic-Assisted Vascular Catheter Placement Procedures by Country, Central & Eastern Europe, 2021 – 2031 (1 of 2)
- Figure 15-10: Robotic-Assisted Vascular Catheter Placement Procedures by Country, Central & Eastern Europe, 2021 – 2031 (2 of 2)
- Figure 15-11: Robotic-Assisted Vascular Catheter Placement Procedures by Country, Middle East, 2021 – 2031
- Figure 15-12: Robotic-Assisted Vascular Catheter Placement Procedures by Country, Asia-Pacific, 2021 – 2031 (1 of 3)
- Figure 15-13: Robotic-Assisted Vascular Catheter Placement Procedures by Country, Asia-Pacific, 2021 – 2031 (2 of 3)
- Figure 15-14: Robotic-Assisted Vascular Catheter Placement Procedures by Country, Asia-Pacific, 2021 – 2031 (3 of 3)
- Figure 15-15: Robotic-Assisted Vascular Catheter Placement Procedures by Country, Africa, 2021 – 2031
- Figure 15-16: Robotic Vascular Catheter System Market by Segment, Global, 2021 – 2031 (US$M)
- Figure 15-17: Robotic Vascular Catheter System Market by Region, Global, 2021 – 2031 (US$M)
- Figure 15-18: System Placement, Robotic Vascular Catheter System Market, Global, 2021 – 2031
- Figure 15-19: Total Systems Placed, Robotic Vascular Catheter System Market, Global, 2021 – 2031
- Figure 15-20: System Leased or Placed under Financial Arrangement, Robotic Vascular Catheter System Market, Global, 2021 – 2031
- Figure 15-21: Robotic Vascular Catheter Capital Equipment Market, Global, 2021 – 2031
- Figure 15-22: Systems Sold under Outright Purchase by Region, Robotic Vascular Catheter Capital Equipment Market, Global, 2021 – 2031
- Figure 15-23: Installed Base by Region, Robotic Vascular Catheter Capital Equipment Market, Global, 2021 – 2031
- Figure 15-24: Average Selling Price by Region, Robotic Vascular Catheter Capital Equipment Market, Global, 2021 – 2031 (US$)
- Figure 15-25: Market Value by Region, Robotic Vascular Catheter Capital Equipment Market, Global, 2021 – 2031 (US$M)
- Figure 15-26: Robotic Vascular Catheter Disposables and Other Accessories Market, Global, 2021 – 2031
- Figure 15-27: Units Sold by Region, Robotic Vascular Catheter Disposables and Other Accessories Market, Global, 2021 – 2031
- Figure 15-28: Average Selling Price by Region, Robotic Vascular Catheter Disposables and Other Accessories Market, Global, 2021 – 2031 (US$)
- Figure 15-29: Market Value by Region, Robotic Vascular Catheter Disposables and Other Accessories Market, Global, 2021 – 2031 (US$M)
- Figure 15-30: Robotic Vascular Catheter System Service and Maintenance Revenue Market, Global, 2021 – 2031
- Figure 15-31: Installed Base Serviced by Region, Robotic Vascular Catheter System Service and Maintenance Revenue Market, Global, 2021 – 2031
- Figure 15-32: Average Selling Price by Region, Robotic Vascular Catheter System Service and Maintenance Revenue Market, Global, 2021 – 2031 (US$)
- Figure 15-33: Market Value by Region, Robotic Vascular Catheter System Service and Maintenance Revenue Market, Global, 2021 – 2031
- Figure 15-34: Leading Competitors, Robotic Vascular Catheter System Market, Global, 2024
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
